Clinical trial

The Effect of Donepezil on Glycemic Control in Type II Diabetics

NCT04507438

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-07-12

PhasePHASE2

Study timeline

Study start (actual)2019-07-12Date precision: day

Registry last updated2023-10-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Donepezil 5-10 Mg Oral TabletDRUG

Placebo Oral TabletDRUG

Sponsors & collaborators

University of Maryland, Baltimorelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04507438 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.